KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Other Non-Current Assets (2017 - 2025)

Amneal Pharmaceuticals has reported Other Non-Current Assets over the past 9 years, most recently at $57.8 million for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $57.8 million for Q4 2025, down 3.87% from a year ago — trailing twelve months through Dec 2025 was $57.8 million (down 3.87% YoY), and the annual figure for FY2025 was $57.8 million, down 3.87%.
  • Other Non-Current Assets for Q4 2025 was $57.8 million at Amneal Pharmaceuticals, up from $39.5 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for AMRX hit a ceiling of $108.3 million in Q3 2022 and a floor of $19.2 million in Q2 2021.
  • Median Other Non-Current Assets over the past 5 years was $59.0 million (2024), compared with a mean of $59.7 million.
  • Biggest five-year swings in Other Non-Current Assets: surged 454.39% in 2022 and later crashed 59.26% in 2024.
  • Amneal Pharmaceuticals' Other Non-Current Assets stood at $20.6 million in 2021, then surged by 400.71% to $103.2 million in 2022, then plummeted by 46.21% to $55.5 million in 2023, then grew by 8.31% to $60.1 million in 2024, then decreased by 3.87% to $57.8 million in 2025.
  • The last three reported values for Other Non-Current Assets were $57.8 million (Q4 2025), $39.5 million (Q3 2025), and $44.8 million (Q2 2025) per Business Quant data.